# Lidocaine

NDC: 0362-0262
Generic name: Lidocaine Hydrochloride and Epinephrine
Labeler / Manufacturer: Septodont, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBMUCOSAL
Marketing started: 20180810

FDA application: ANDA088389

## Active ingredients

- EPINEPHRINE BITARTRATE: .02 mg/mL
- LIDOCAINE HYDROCHLORIDE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0362-0262"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0362-0262
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df130310-41db-45df-a214-9da01cf0bf41